Is the optimal dose of angiotensin-converting enzyme inhibitors in patients with congestive heart failure definitely established?

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2096-2097

  Delahaye, François ^a   De Gevigney, Guy ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; LISINOPRIL; PLACEBO;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; HEART EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENALAPRIL; HEART FAILURE, CONGESTIVE; HUMANS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033667439     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01026-3     Document Type: Editorial

References (15)

1. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: A multicenter study
2. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
4. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
5. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure
6. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
7. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
8. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study
9. ACE inhibitors for heart failure: A question of dose
10. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
11. ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomised Aldactone Evaluation Study (RALES)
12. Prevalence, aetiology and management of heart failure in general practice
13. Severity of heart failure and dosage of angiotensin converting enzyme inhibitors
14. Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: Are we ignoring the evidence?
15. Comparison of treatment with lisinopril versus enalapril for congestive heart failure